FUNDAMENTALS |
MarketCap: |
0.281 mill
|
EPS: |
-0.520
|
P/E: |
-0.120
|
Earnings Date: |
May 10, 2023 |
SharesOutstanding: |
4.54 mill
|
Avg Daily Volume: |
0.0012 mill
|
RATINGS |
Rating CashFlow: |
Sell
|
|
Return On Equity: |
Buy
|
|
Return On Asset: |
Strong Sell
|
|
DE: |
Strong Sell
|
|
P/E: |
Sell
|
|
Price To Book: |
Strong Sell
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | | | n/a | n/a | n/a | n/a |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -0.120 | sector: PE -11.58
|
PE RATIO: COMPANY / INDUSTRY |
-0.02x
|
Company: PE -0.120 | industry: PE 4.94
|
DISCOUNTED CASH FLOW VALUE |
N/A
|
N/A
|
Expected Trading Range (DAY) |
$ 0.0580 - 0.0660
( +/- 6.45%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2023-01-31 | Mcmorran Doreen | Buy | 12 562 975 | Debt Conversion Rights (Warrant) |
2023-01-31 | Mcmorran Doreen | Buy | 25 125 950 | Debt Conversion Rights |
2023-01-31 | Mcmorran Doreen | Buy | 12 562 975 | Debt Conversion Rights (Warrant) |
2023-01-31 | Mcmorran Doreen | Buy | 25 125 950 | Debt Conversion Rights |
2023-01-31 | Howlett Terry | Buy | 14 299 035 | Debt Conversion Rights (Warrant) |
INSIDER POWER |
100.00
|
Last
99 transactions |
Buy:
392 316 110 | Sell:
755 909 |
Forecast:
12:02 - $0.0620
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
Volume Signals |
Price |
$0.0620 (0.00% )
|
Volume |
0.0016 mill
|
Avg. Vol. |
0.0012 mill
|
% of Avg. Vol |
135.28 %
|
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SKVI
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company offers sunless tanning and sunscreen products under the Skinbrella name. It also licenses to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.